Readdressing the role of surgery of the primary tumor in de novo stage IV breast cancer

Seema Ahsan Khan*, Elizabeth S.M. DesJardin

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

The impressive advances in breast cancer treatment observed in recent years also apply to the metastatic setting, where a subset of patients with favorable metastatic disease enjoy long-term survival with systemic therapy. In patients with distant disease, the primary tumor in the breast has not classically been though to merit specific locoregional therapy. However, about 6% of Stage IV patients in the USA and up to 20% in limited resource environments present with synchronous distant metastases at the time of initial diagnosis. For this group, who have an intact primary tumor, retrospective studies suggest that local therapy for the primary site may be beneficial. However, these retrospective analyses are biased in that women receiving local therapy to the primary site were younger and had biologically favorable tumors and lower volume metastatic disease. Two completed randomized clinical trials have shown conflicting results, and others are ongoing. In this chapter, we discuss the results of these studies through the present day and summarize their conclusions and their implications for clinical management.

Original languageEnglish (US)
Title of host publicationCancer Treatment and Research
PublisherSpringer International Publishing
Pages73-88
Number of pages16
DOIs
StatePublished - Jan 1 2018

Publication series

NameCancer Treatment and Research
Volume173
ISSN (Print)0927-3042

Fingerprint

Breast Neoplasms
Neoplasms
Therapeutics
Tumor Burden
Randomized Controlled Trials
Retrospective Studies
Neoplasm Metastasis
Survival

Keywords

  • Local therapy
  • Locoregional therapy
  • Metastatic breast cancer
  • Stage IV breast cancer
  • Surgery
  • Survival

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Khan, S. A., & DesJardin, E. S. M. (2018). Readdressing the role of surgery of the primary tumor in de novo stage IV breast cancer. In Cancer Treatment and Research (pp. 73-88). (Cancer Treatment and Research; Vol. 173). Springer International Publishing. https://doi.org/10.1007/978-3-319-70197-4_6
Khan, Seema Ahsan ; DesJardin, Elizabeth S.M. / Readdressing the role of surgery of the primary tumor in de novo stage IV breast cancer. Cancer Treatment and Research. Springer International Publishing, 2018. pp. 73-88 (Cancer Treatment and Research).
@inbook{bfa1440638664fa295194ab065007621,
title = "Readdressing the role of surgery of the primary tumor in de novo stage IV breast cancer",
abstract = "The impressive advances in breast cancer treatment observed in recent years also apply to the metastatic setting, where a subset of patients with favorable metastatic disease enjoy long-term survival with systemic therapy. In patients with distant disease, the primary tumor in the breast has not classically been though to merit specific locoregional therapy. However, about 6{\%} of Stage IV patients in the USA and up to 20{\%} in limited resource environments present with synchronous distant metastases at the time of initial diagnosis. For this group, who have an intact primary tumor, retrospective studies suggest that local therapy for the primary site may be beneficial. However, these retrospective analyses are biased in that women receiving local therapy to the primary site were younger and had biologically favorable tumors and lower volume metastatic disease. Two completed randomized clinical trials have shown conflicting results, and others are ongoing. In this chapter, we discuss the results of these studies through the present day and summarize their conclusions and their implications for clinical management.",
keywords = "Local therapy, Locoregional therapy, Metastatic breast cancer, Stage IV breast cancer, Surgery, Survival",
author = "Khan, {Seema Ahsan} and DesJardin, {Elizabeth S.M.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/978-3-319-70197-4_6",
language = "English (US)",
series = "Cancer Treatment and Research",
publisher = "Springer International Publishing",
pages = "73--88",
booktitle = "Cancer Treatment and Research",

}

Khan, SA & DesJardin, ESM 2018, Readdressing the role of surgery of the primary tumor in de novo stage IV breast cancer. in Cancer Treatment and Research. Cancer Treatment and Research, vol. 173, Springer International Publishing, pp. 73-88. https://doi.org/10.1007/978-3-319-70197-4_6

Readdressing the role of surgery of the primary tumor in de novo stage IV breast cancer. / Khan, Seema Ahsan; DesJardin, Elizabeth S.M.

Cancer Treatment and Research. Springer International Publishing, 2018. p. 73-88 (Cancer Treatment and Research; Vol. 173).

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Readdressing the role of surgery of the primary tumor in de novo stage IV breast cancer

AU - Khan, Seema Ahsan

AU - DesJardin, Elizabeth S.M.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The impressive advances in breast cancer treatment observed in recent years also apply to the metastatic setting, where a subset of patients with favorable metastatic disease enjoy long-term survival with systemic therapy. In patients with distant disease, the primary tumor in the breast has not classically been though to merit specific locoregional therapy. However, about 6% of Stage IV patients in the USA and up to 20% in limited resource environments present with synchronous distant metastases at the time of initial diagnosis. For this group, who have an intact primary tumor, retrospective studies suggest that local therapy for the primary site may be beneficial. However, these retrospective analyses are biased in that women receiving local therapy to the primary site were younger and had biologically favorable tumors and lower volume metastatic disease. Two completed randomized clinical trials have shown conflicting results, and others are ongoing. In this chapter, we discuss the results of these studies through the present day and summarize their conclusions and their implications for clinical management.

AB - The impressive advances in breast cancer treatment observed in recent years also apply to the metastatic setting, where a subset of patients with favorable metastatic disease enjoy long-term survival with systemic therapy. In patients with distant disease, the primary tumor in the breast has not classically been though to merit specific locoregional therapy. However, about 6% of Stage IV patients in the USA and up to 20% in limited resource environments present with synchronous distant metastases at the time of initial diagnosis. For this group, who have an intact primary tumor, retrospective studies suggest that local therapy for the primary site may be beneficial. However, these retrospective analyses are biased in that women receiving local therapy to the primary site were younger and had biologically favorable tumors and lower volume metastatic disease. Two completed randomized clinical trials have shown conflicting results, and others are ongoing. In this chapter, we discuss the results of these studies through the present day and summarize their conclusions and their implications for clinical management.

KW - Local therapy

KW - Locoregional therapy

KW - Metastatic breast cancer

KW - Stage IV breast cancer

KW - Surgery

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=85041078955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041078955&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-70197-4_6

DO - 10.1007/978-3-319-70197-4_6

M3 - Chapter

T3 - Cancer Treatment and Research

SP - 73

EP - 88

BT - Cancer Treatment and Research

PB - Springer International Publishing

ER -

Khan SA, DesJardin ESM. Readdressing the role of surgery of the primary tumor in de novo stage IV breast cancer. In Cancer Treatment and Research. Springer International Publishing. 2018. p. 73-88. (Cancer Treatment and Research). https://doi.org/10.1007/978-3-319-70197-4_6